IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

U.S. Enzyme Sales to Top $2.8 Billion in 2014

4:19 AM MDT | September 14, 2010 | Alex Scott

Sales of enzymes in the U.S. are set to increase 4.8%/year, to $2.8 billion in 2014, according to research by Freedonia Group (Cleveland, OH), a market research firm. Much of the growth will come from the increasing use of enzymes for pharmaceutical applications, and to a lesser extent for processing cellulosic ethanol. Carbohydrases will continue to be the largest selling enzyme product type.   To date, the biofuels enzyme product mix has been dominated by alpha amylases and glucoamylases used in conventional starch-based ethanol processing. Through...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa